Provided by Tiger Trade Technology Pte. Ltd.

Applied Therapeutics Inc.

0.1250
+0.00141.13%
Post-market: 0.12620.0012+0.96%19:59 EST
Volume:5.57M
Turnover:707.86K
Market Cap:18.04M
PE:-0.98
High:0.1329
Open:0.1221
Low:0.1216
Close:0.1236
52wk High:1.50
52wk Low:0.1000
Shares:144.30M
Float Shares:120.21M
Volume Ratio:0.37
T/O Rate:4.64%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1280
EPS(LYR):-0.7570
ROE:-680.47%
ROA:-88.35%
PB:-32.15
PE(LYR):-0.17

Loading ...

Company Profile

Company Name:
Applied Therapeutics Inc.
Exchange:
NASDAQ
Establishment Date:
2016
Employees:
28
Office Location:
545 Fifth Avenue,Suite 1400,New York,New York,United States
Zip Code:
10017
Fax:
- -
Introduction:
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target central nervous system rare disease and diabetic complications in the United States. Its lead product candidate is AT-007 that has completed phase III for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study for the treatment of galactosemia in kids; for treating sorbitol dehydrogenase deficiency; and for the treatment of phosphomannomutase enzyme-CDG. The company also develops AT-001 that is in phase III clinical trials to treat diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy; and AT-003, which is in preclinical studies for the treatment diabetic retinopathy. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York.

Directors

Name
Position
Les Funtleyder
Director,Interim Chief Executive Officer and Chief Financial Officer
Jay S. Skyler
Director
Stacy J. Kanter
Director

Shareholders

Name
Position
Les Funtleyder
Director,Interim Chief Executive Officer and Chief Financial Officer
Constantine Chinoporos
Chief Operating Officer and Chief Business Officer
Catherine Thorpe
Interim Chief Accounting Officer
Dale Hooks
Chief Commercial Officer
Evan P. Bailey
Chief Medical Officer